Loading...
Bruker reported Q3 2024 revenues of $864.4 million, a 16.4% increase year-over-year. GAAP diluted EPS was $0.27, and non-GAAP diluted EPS was $0.60. The company updated its FY2024 guidance, expecting revenues of $3.34 to $3.37 billion and non-GAAP EPS of $2.36 to $2.41.
Q3 2024 revenues reached $864.4 million, a 16.4% increase year-over-year.
Bruker organic revenue grew by 3.1% year-over-year.
GAAP diluted EPS was $0.27, while non-GAAP diluted EPS was $0.60.
FY2024 revenue is projected to be $3.34 to $3.37 billion, with organic revenue growth of 3% to 4%.
Bruker expects FY2024 revenues of $3.34 to $3.37 billion, with organic revenue growth of 3% to 4%, and non-GAAP EPS of $2.36 to $2.41.